From symptom relief to household control: baloxavir redefines antiviral strategies for influenza.
作者信息
Xu Jin-Fu, Liu Yang, Zhang Panpan, Cao Bin
机构信息
Department of Respiratory and Critical Care Medicine, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, 100054, China.
出版信息
Lancet Reg Health West Pac. 2025 Aug 2;61:101651. doi: 10.1016/j.lanwpc.2025.101651. eCollection 2025 Aug.
Abstract
摘要
相似文献
1
From symptom relief to household control: baloxavir redefines antiviral strategies for influenza.
Lancet Reg Health West Pac. 2025 Aug 2;61:101651. doi: 10.1016/j.lanwpc.2025.101651. eCollection 2025 Aug.
2
Clinical efficacy of baloxavir marboxil versus oseltamivir in kidney transplant recipients with influenza.
Microbiol Spectr. 2025 Jul;13(7):e0295424. doi: 10.1128/spectrum.02954-24. Epub 2025 May 22.
3
Efficacy and safety of single-dose antiviral drugs for influenza treatment: A systematic review and network meta-analysis.
J Med Virol. 2022 Jul;94(7):3270-3302. doi: 10.1002/jmv.27729. Epub 2022 Apr 4.
4
[A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients].
Ter Arkh. 2020 Dec 26;92(11):122-131. doi: 10.26442/00403660.2020.11.000870.
5
Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis.
Lancet. 2024 Aug 24;404(10454):764-772. doi: 10.1016/S0140-6736(24)01357-6.
6
Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza.
J Chemother. 2024 Jul;36(4):267-282. doi: 10.1080/1120009X.2023.2263270. Epub 2023 Sep 28.
7
Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey.
Infect Dis Ther. 2024 Apr;13(4):685-697. doi: 10.1007/s40121-024-00937-y. Epub 2024 Mar 14.
8
Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
Clin Infect Dis. 2021 Jun 1;72(11):e859-e867. doi: 10.1093/cid/ciaa1622.
9
Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.
Antiviral Res. 2025 Sep;241:106217. doi: 10.1016/j.antiviral.2025.106217. Epub 2025 Jun 24.
10
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
N Engl J Med. 2025 Apr 24;392(16):1582-1593. doi: 10.1056/NEJMoa2413156.
本文引用的文献
1
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
N Engl J Med. 2025 Apr 24;392(16):1582-1593. doi: 10.1056/NEJMoa2413156.
2
Real-world effectiveness and safety of Baloxavir Marboxil or Oseltamivir in outpatients with uncomplicated influenza A: an ambispective, observational, multi-center study.
Front Microbiol. 2024 Jul 23;15:1428095. doi: 10.3389/fmicb.2024.1428095. eCollection 2024.
3
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.
Influenza Other Respir Viruses. 2024 May;18(5):e13302. doi: 10.1111/irv.13302.
4
Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey.
Infect Dis Ther. 2024 Apr;13(4):685-697. doi: 10.1007/s40121-024-00937-y. Epub 2024 Mar 14.
5
Comparison of clinical efficacy and safety of baloxavir marboxil versus oseltamivir as the treatment for influenza virus infections: A systematic review and meta-analysis.
J Infect Chemother. 2024 Mar;30(3):242-249. doi: 10.1016/j.jiac.2023.10.017. Epub 2023 Oct 20.
6
Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017-18 (PHIRST): a population cohort study.
Lancet Glob Health. 2021 Jun;9(6):e863-e874. doi: 10.1016/S2214-109X(21)00141-8.
7
Influenza vaccination: protecting the most vulnerable.
Eur Respir Rev. 2021 Jan 13;30(159). doi: 10.1183/16000617.0258-2020. Print 2021 Mar 31.
8
Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
N Engl J Med. 2020 Jul 23;383(4):309-320. doi: 10.1056/NEJMoa1915341. Epub 2020 Jul 8.
9
Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study.
Lancet Public Health. 2019 Sep;4(9):e473-e481. doi: 10.1016/S2468-2667(19)30163-X.
Zotero 插件